Navigation Links
Napo in Medical News

Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals

... SAN FRANCISCO, Dec. 10 /PRNewswire/ -- napo Pharmaceuticals, Inc. ("Napo") is pleased to annou... of $500,000 for the purchase of 250,000 shares of napo common stock; as well as regulatory and sales mile...llaboration Agreement) will include a reference to napo as the licensor and will include Napo's logo and r...

Napo Obtains Special Protocol Assessment Agreement From FDA for Crofelemer

... napo Pharmaceuticals, Inc., which focuses on the develo...r an FDA Fast Track designation. On Jan. 16, 2007, napo met with the FDA under the Special Protocol Assess...ive design of its ADVENT trial. On March 14, 2007, napo announced it had received approval from the princi...
Napo in Medical Technology

Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera

... SAN FRANCISCO, Sept. 22 /PRNewswire/ -- napo Pharmaceuticals (LSE: NAPL/NAPU) today announces p...tic, azithromycin, and rehydration therapy. Both napo and ICDDR, B, upon receipt of additional funding, ...al Institutes of Allergy and Infectious Disease. napo is currently conducting a Phase 3 trial for crofel...

Napo Presents at ISPOR Meeting in Toronto

...um of anti-retroviral drugs. We are pleased to see napo taking the initiative to develop this new instrume...rhea." For more information please contract: napo Pharmaceuticals, Inc. Lisa Conte, Chief Executive...ector, Clinical Operations 1+ 760 918 5718 About napo Pharmaceuticals, Inc. ...

Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea

...n travelers in Mexico and Jamaica with crofelemer, napo is investigating the regulatory pathway to file an...diarrhea in people living with HIV/AIDS (CRO-HIV). napo is targeting an NDA filing for CRO-HIV around the end of the year. napo has exclusive worldwide rights to crofelemer in al...

Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea

...ritories, Glenmark will pay ascending royalties to napo on sales of crofelemer for these indications. Gl...3 2008." For more information please contact: napo Pharmaceuticals, Inc. Lisa Conte, Chief Executive... 7466 5000 Tim Anderson, Mary-Jane Johnson About napo Pharmaceuticals, Inc. ...

Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.

...CO, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- napo Pharmaceuticals, Inc., , which focuses on the deve... licensed crofelemer for the d-IBS indication from napo in June 2004. Trine has worldwide development and ... For more information please contact: napo Pharmaceuticals, Inc Lisa Conte, Chief Execut...
Napo in Biological Technology

Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results

...MMD trial. This was partially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX(TM) in the short stature...00,000 loss on investments represents the full write down on the prior year napo investment during 2008. As of December 31, 2008, we had total cash, ca...

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

...m Napo, was recorded as part of our agreement with napo in 2007. For the nine months ended September 30,...ially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX... investments represents the full write down of the napo investment during the first nine months of 2008. ...

Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)

...ar NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- napo Pharmaceuticals, Inc., ("Napo") of South San Franc...uch as HIV/AIDS and cholera. As part of the CAP, napo and Direct Relief International ("DRI") have formed an alliance whereby napo will provide CRO-PED at cost for distribution thro...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008

... absence of license income from our agreement with napo Pharmaceuticals Inc., ("Napo") from which we recei...ially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX...ss on investments represents the write down on the napo investment during the first half of 2008. Intere...

Insmed Announces First Quarter 2008 Financial Results

...and Tercica Inc., and the absence of license income from our agreement with napo Pharmaceuticals Inc., ("Napo") from which we received a milestone payment i...y a milestone payment from Napo, was recorded as part of our agreement with napo in 2007. Interest income in the first quarter of 2008 at $279,000 was sli...

IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference

... Group Ltd. Hoersholm, Denmark Santaris BioPharmaceutical Pharmaceutical California, USA napo Pharmaceutical BioPharmaceutical Wurmlingen, Paradigm Spine, LLC Devices Germany Tokyo, Japan EyePlusPlus,...

Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results

...ng period of 2006. This increase was due to improvements in the cost recovery from our EAP and the receipt of licensing income from our agreement with napo Pharmaceuticals Inc., ("NAPO"), combined with increased sales of IPLEX(TM) during the first quarter of 2007. The net loss for the 12 months ended De...

M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer

...pany as Chief Medical Officer. Prior to joining Ocera, Dr. Harris held the position of Chief Medical Officer and Vice President of Clinical Affairs at napo Pharmaceuticals. Dr. Harris has extensive experience in gastrointestinal diseases as well as clinical and regulatory operations. "We are delighted b...
Other Tags
(Date:7/27/2014)... Bags underneath the eyes is one condition ... there are a range of new products now available from ... baggy eyes serum review that is now posted for adults ... the issues with baggy eyes and how the natural ingredients ... The guide also provides a detailed overview of the creams ...
(Date:7/27/2014)... The report, “Glass Fiber & ... Raw Material, By Manufacturing Process, By Application (Transportation, ... Geography – Global Trends & Forecast to 2019”, ... with an analysis and forecast by value and ... 107 figures spread through 347 slides and in-depth ...
(Date:7/27/2014)... Prominent Vancouver Chiropractors, Dr. Shervin Ranjbar and ... hamstring release procedure in Vancouver, BC. Both these chiropractors ... and have years of experience in the field of ... by the two professionals using a foam roller exercise. ... release tight hamstrings and relieve the client of the ...
(Date:7/27/2014)... City (Sunday July 27 11:45 am ET): ... at the surgical sitehas been reduced by 77 ... in the American College of Surgeons National Surgical ... new case study presented at the 2014 ACS ... British Columbia, reportedly reduced its rate of cardiac ...
(Date:7/27/2014)... 2014 Metachromatic leukodystrophy (MLD, also ... disease which is commonly listed in the family ... as it affects the metabolism of sphingolipids. Leukodystrophies ... fatty covering which acts as an insulator around ... systems. MLD involves cerebroside sulfate accumulation. Metachromatic leukodystrophy, ...
Breaking Medicine News(10 mins):Health News:Baggy Eyes Serum Review Posted for Men and Women at Cherry News Website 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 2Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 3Health News:Major Drivers for GFRP Composites Market in Future – Report by MarketsandMarkets 4Health News:Renowned Vancouver Chiropractors Demonstrates Hamstring Release in Vancouver, BC 2Health News:Surgical safety program greatly reduces surgical site infections for heart operations 2Health News:Surgical safety program greatly reduces surgical site infections for heart operations 3Health News:Surgical safety program greatly reduces surgical site infections for heart operations 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 2Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 3Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 4Health News:Metachromatic Leukodystrophy Therapeutics Clinical Trials Market Review H2 2014 Report Available at LifeScienceIndustryResearch.com 5
(Date:7/25/2014)... a molecular testing panel developed at UPMC greatly ... surgery for patients with thyroid nodules and cancer, ... Institute (UPCI), partner with UPMC CancerCenter., The test, ... other diagnostic testing agencies, improved the chances of ... percent, according to the study published this month ...
(Date:7/25/2014)... 25, 2014 Biometrics industry expands ... to digital technology for online & commerce payments while ... (NASDAQ: GOOG ), LifeLock Inc. (NYSE: ... ), Apple Inc. (NASDAQ: AAPL ) and ... NXTD) a biometric authentication company focused on the growing ...
(Date:7/24/2014)... many sobering examples of how wildlife loss leads to ... co-authored by Wildlife Conservation Society (WCS) Health & ... Golden, calls for an interdisciplinary approach to tackle global ... supports about 15% of the world,s people and provides ... poor. It should come as no surprise that today,s ...
Breaking Biology News(10 mins):Test increases odds of correct surgery for thyroid cancer patients 2Test increases odds of correct surgery for thyroid cancer patients 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 2Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 3Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 4Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 5Consumer Needs for Identity Theft Security Grows with Popularity of Latest Smart Technology Products - Biometrically Secure Digital Wallet to Replace Credit Card Dependency 6New study draws links between wildlife loss and social conflicts 2
Other Contents